A
Amaya Sanz-Rodriguez
Researcher at Royal College of Surgeons in Ireland
Publications - 26
Citations - 1185
Amaya Sanz-Rodriguez is an academic researcher from Royal College of Surgeons in Ireland. The author has contributed to research in topics: Status epilepticus & Epilepsy. The author has an hindex of 15, co-authored 24 publications receiving 939 citations.
Papers
More filters
Journal ArticleDOI
miRNA Expression Profile after Status Epilepticus and Hippocampal Neuroprotection by Targeting miR-132
Eva M. Jimenez-Mateos,Isabella Bray,Amaya Sanz-Rodriguez,Tobias Engel,Ross C. McKiernan,Genshin Mouri,Genshin Mouri,Katsuhiro Tanaka,Katsuhiro Tanaka,Takanori Sano,Takanori Sano,Julie A. Saugstad,Roger P. Simon,Raymond L. Stallings,Raymond L. Stallings,David C. Henshall +15 more
TL;DR: The data suggest that miRNAs are important regulators of seizure-induced neuronal death, and in tolerant animals, expression responses of >40% of the injury-group-detected mi RNAs differed, being either unchanged relative to control or down-regulated, and this included miR-132.
Journal ArticleDOI
Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice
Tobias Engel,Rosa Gómez-Villafuertes,Rosa Gómez-Villafuertes,Katsuhiro Tanaka,Guillaume Mesuret,Amaya Sanz-Rodriguez,Paula García-Huerta,Paula García-Huerta,M. Teresa Miras-Portugal,M. Teresa Miras-Portugal,David C. Henshall,Miguel Díaz-Hernández,Miguel Díaz-Hernández +12 more
TL;DR: It is reported that SE induced by intra‐amygdala kainic acid in mice selectively increased hippocampal levels of P2X7 receptors relative to other P2 X receptors, suggesting that P2x7 receptor antagonists may be a promising class of drug for seizure abrogation and neuroprotection in SE.
Journal ArticleDOI
Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079
Alba Jimenez-Pacheco,Guillaume Mesuret,Amaya Sanz-Rodriguez,Katsuhiro Tanaka,Claire M. Mooney,Ronan M. Conroy,María Teresa Miras-Portugal,Miguel Díaz-Hernández,David C. Henshall,Tobias Engel +9 more
TL;DR: The present study was designed to characterize P2X7R in the neocortex and assess effects of P2x7R antagonists on cortical injury after status epilepticus.
Journal ArticleDOI
Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy
Alba Jimenez-Pacheco,Miguel Díaz-Hernández,Marina Arribas-Blázquez,Amaya Sanz-Rodriguez,Luis Alcides Olivos-Oré,Antonio R. Artalejo,Mariana Alves,Michael A. Letavic,M. Teresa Miras-Portugal,Ronan M. Conroy,Norman Delanty,Michael A. Farrell,Donncha F. O’Brien,Anindya Bhattacharya,Tobias Engel,David C. Henshall +15 more
TL;DR: Targeting the receptor with a new centrally available antagonist, JNJ-47965567, suppressed epileptic seizures well beyond the time of treatment and reduced underlying gliosis in the hippocampus, suggesting a potential disease-modifying treatment for epilepsy based on targeting the P2X7 receptor.
Journal ArticleDOI
microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus
Eva M. Jimenez-Mateos,Marina Arribas-Blázquez,Amaya Sanz-Rodriguez,Caoimhín G. Concannon,Luis Alcides Olivos-Oré,Cristina R. Reschke,Claire M. Mooney,Catherine Mooney,Eleonora Lugarà,James Morgan,Elena Langa,Alba Jimenez-Pacheco,Luiz Fernando Almeida Silva,Guillaume Mesuret,Detlev Boison,M. Teresa Miras-Portugal,Michael A. Letavic,Antonio R. Artalejo,Anindya Bhattacharya,Miguel Díaz-Hernández,David C. Henshall,Tobias Engel +21 more
TL;DR: A role for post-transcriptional regulation of the P2X7R is supported and therapeutic targeting of microRNA-22 may prevent inflammation and development of a secondary epileptogenic focus in the brain is suggested.